Ablatherm safety on longterm results

1
Ablatherm safety on long-term results

• Dr. A. BlanaRegensburg, Germany

2
Patients characteristics

• Mean follow-up 6.4 1.1 years
• Mean age 69.1 6.6 years
• Mean number of HIFU sessions 1.3

51.4 Low risk48.6 Intermediate risk
54.3 Prototype 45.7 Commercialized device
3
Urinary incontinence
94.3 Continent 5 Incontinence Grade I 0.7
Incontinence Grade II
4
Erectile dysfunction

• Evaluation
• Erectile dysfunction
• Partial erectile dysfunction
• Some erection but intercourse not possible
• Potent
• Intercourse possible

5
Erectile dysfunction on 100 previously potent
patients

• Last Evaluation

46 Potent 21 Impotent 14 Partially
impotent 19 unknown
6
Other treatment-related morbidity

• Urinary infection
• 10 patients (7.1 )
• Obstruction
• 19 patients (13.6)
• Transient pelvic pain
• 8 patients (5.7)

7
Non presented adverse reactions

• No recto-urethral fistula
• No grade III urinary incontinence
• No blood transfusion
• No treatment related death

8
Conclusion

• No unexpected late complications
• 46 of the patients claimed sexual function
• 94.3 had no need for pads